Change of Adviser

RNS Number : 0537Y
Proteome Sciences PLC
04 September 2015
 

Proteome Sciences plc

(the "Company")

 

Appointment of Nominated Adviser and Broker

 

The Board is pleased to announce that finnCap has been appointed as Nominated Adviser and sole Broker to the Company with immediate effect.

 

 

For further information please contact:

 

Proteome Sciences plc

Christopher Pearce, Executive Chairman

Dr. Ian Pike, Chief Operating Officer

Geoff Ellis, Finance Director

Tel: (0)1932 865065

 

 

finnCap Ltd (nominated adviser & broker)         

Geoff Nash / James Thompson

Tel: (0)207 220 0500

 

Notes for editors:

About Proteome Sciences plc (www.proteomics.com)

Proteome Sciences is a global leader in applied proteomics and peptidomics offering high sensitivity, proprietary technologies for protein and peptide biomarker discovery, validation and assay development. The Company is headquartered in Cobham, UK, with laboratory facilities in London and Frankfurt.

Proteome Sciences' proprietary research has discovered a large number of novel protein biomarkers in key human diseases and is focused mainly in neurological/neurodegenerative conditions and in cancer. It has discovered and patented blood biomarkers in Alzheimer's disease, stroke, brain damage and lung cancer for diagnostic and treatment applications that are available for license or have already been outlicensed.

The Company's PS Biomarker Services division provides outsourced proteomics services and proprietary biomarker assays to pharmaceutical, biotechnology and diagnostics companies from its ISO 9001: 2008 facility in Frankfurt, Germany.


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
APPLLFERASIVIIE
UK 100

Latest directors dealings